GNRH1 and ovarian hyperstimulation syndrome: The results showed that the incidence of OHSS was lower in the GnRH antagonist group than in the GnRH agonist group, and this difference was statistically significant (OR:0.59,95%CI:0.42∼0.82; P = 0.002; Figure 5).